One Drug for Two Problems, or Two Drugs Done Right
A treatment-naive man has both bothersome urinary symptoms and erectile dysfunction. One drug is labeled for both. The question is whether treating both problems adequately beats treating one problem well.
J.P., 58, runs his own auto repair shop out of a garage he built himself twenty years ago, and still does most of the physical work despite two employees who could take more of it off his hands. He came in for a routine check and, somewhat reluctantly, brought up two things he'd been putting off mentioning: a weakening urinary stream and hesitancy that's made bathroom breaks a real interruption to his workday, and erectile dysfunction he's had for at least three years but never sought treatment for. He has never taken a medication for either problem.
His AUA symptom score is 15, in the moderate-to-severe range, driven mostly by weak stream and incomplete emptying rather than urgency or frequency. His prostate is mildly enlarged on exam, around 32mL, without nodularity, and his uroflowmetry shows a peak flow of 9mL/s — comfortably below the 10-12mL/s range that typically separates a mechanically obstructed stream from a merely bothersome one, which is the objective finding underneath his subjective complaint about losing time at work. His ED, by his own report using a validated symptom questionnaire, is moderate and has been stable rather than worsening. He has well-controlled hypertension on a single agent, no diabetes, and no other medications that would complicate starting a PDE5 inhibitor or an alpha-blocker. He's asked directly whether there's "one thing" that could handle both problems, since he'd rather not juggle two new prescriptions if one will do — a preference he's stated partly out of habit, having gone years without seeing a doctor regularly at all, and partly out of genuine reluctance to add complexity to a daily routine that starts before six most mornings.
Whether "one drug for both" is actually the efficient choice
Tadalafil 5mg daily is labeled for exactly his combined presentation, and he's never been treated for either problem before. One prescription addressing both, rather than starting two new medications at once, matches what he's actually asked for and keeps this simple for a patient just starting treatment.
Simplicity is worth something, but his AUA score of 15 is driven by weak stream and incomplete emptying — flow-related symptoms — and tadalafil's own trial data show a meaningfully smaller effect on peak flow rate than alpha-blockers achieve. If his primary complaint is flow, starting with the drug that moves flow less isn't the efficient choice, it's a compromise on his dominant problem in exchange for convenience.
I'd rather treat his stated primary complaint with the drug best suited to it and handle his ED alongside it, not instead of it.
You're both describing this as a trade-off, and it doesn't have to be one. Tamsulosin and tadalafil have real combination safety data behind them, and tamsulosin specifically — unlike a less selective alpha-blocker — carries a manageable orthostatic risk when combined with a PDE5 inhibitor. Start both together with basic blood-pressure counseling, and he gets the flow benefit the urologist wants and the labeled ED treatment he originally asked about, without waiting on either.
Agreed: start tamsulosin and tadalafil 5mg daily concurrently, with orthostatic blood-pressure counseling given directly, and follow-up flow study plus symptom inventories for both conditions at six weeks.
Not agreed: if his flow rate doesn't improve adequately at follow-up, whether to escalate the alpha-blocker dose or add a 5-alpha-reductase inhibitor next, since his gland size was not emphasized as particularly large. That decision was left for the follow-up visit.